IDEX (IEX) Q4 2002 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2002 earnings summary
9 Nov, 2026Executive summary
2002 sales rose 2% to $742.0M; base-business sales fell 2%, offset by acquisitions and currency. Net income was $54.1M, up 65% reported and 23% excluding 2001 goodwill and trademark amortization.
Operational improvements lifted gross margin 1.6 percentage points and drove record free cash flow of $89.1M, up 6% YoY.
Financial highlights
Operating income rose 37% to $100.4M and operating margin reached 13.5% vs. 10.1%; the comparison reflects no goodwill amortization in 2002 and a 2001 restructuring charge.
Gross profit increased to $281.4M from $263.7M; gross margin was 37.9% vs. 36.3%, supported by sourcing, productivity initiatives and facility consolidation.
Diluted EPS was $1.67 vs. $1.05; 2001 adjusted to exclude goodwill and trademark amortization was $1.42 per diluted share.
Operating cash flow was $108.4M; capital expenditures were $19.3M and free cash flow was $89.1M.
Outlook and guidance
2003 markets were expected to remain sluggish with limited visibility; the short-cycle business plan did not depend on an economic recovery.
Expected further gross and operating margin expansion and greater savings flow-through to earnings in 2003, supported by operational excellence and lower costs.
Global sourcing savings were expected to exceed 2002’s $11.8M as company-wide sourcing and supplier qualification efforts expanded.
Organic-growth initiatives were expected to become standard across operations in 2003; acquisition activity and integration efforts were also expected to continue.
Latest events from IDEX
- Pump Products led FY2003 results as diversified industrial operations managed short backlogs and legal uncertainty.IEX
Q4 2003 - Pump Products led 2004 sales and income as acquisitions broadened the global portfolio.IEX
Q4 2004 - Organic growth accelerated to 10%, while international and acquisition risks remain material.IEX
Q4 2005 - Organic growth, acquisitions and Lean gains lifted sales and margins in 2006.IEX
Q4 2006 - Organic growth and higher gross margin lifted FY07 earnings as acquisition activity expanded the portfolio.IEX
Q4 2007 - Acquisitions lifted sales 10%, but impairment, restructuring and weak dispensing demand cut earnings.IEX
Q4 2008 - Broad organic weakness cut FY09 sales 11%, while cash flow funded operations and investment.IEX
Q4 2009 - FY10 recovery lifted sales 14% and operating margin to 16.5%; FY11 EPS guided to $2.23–$2.33.IEX
Q4 2010 - FY11 sales climbed 22%; FY12 diluted EPS guidance was $2.74–$2.82.IEX
Q4 2011